Positive Impact of Complementary Traditional Chinese Medicine on Symptom Management and Quality of Life in Breast Cancer Patients

• by Chien-Wei Tseng, Ya-Ting Hsu, Jing-Shiang Hwang, Yao-Jen Chang, Hsien-Chang Wu

• April 20, 2026

Roswell Park at ASCO 2026: GLP-1s and Aggressive Breast Cancer, CAR T in Older Adults, AI-Informed Benchmarking

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago

• by

• May 25, 2026

• 9 min

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

• by Inês Nobre, Marlene N. Silva, Sofia Franco, Bruno Rodrigues, Pedro F. Silva, Pedro J. Teixeira, Eliana V. Carraça

• May 14, 2026

Case Report: response of HER2-positive ductal carcinoma in situ to osimertinib with supporting in vitro evidence

• by Shogo Baba, Mami Koketsu, Hajime Kuroda, Megumi Suzuki, Hiroshi Nishihara, Yasutaka Kato, Hiroyuki Kawami, Oi Harada

• May 20, 2026